Cognoa
Healthcare Services · California, United States · 51-200 Employees
View Company Info for Free
Overview
Headquarters
2185 Park Blvd, Palo Alto, California, 9...Phone Number
(650) 391-9402Website
www.cognoa.comRevenue
$9.9 MillionIndustry
ZI Rank: 5
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
4
5
3
3
3
5
About Cognoa
Cognoa is a company focused on early childhood development and pediatric behavioral health, offering digital diagnostics and therapeutics aimed at improving access to care for children and families. Their flagship product, Canvas Dx, is the first FDA-authorized diagnostic solution that enables clinicians to diagnose or rule out autism in children aged 1.5 to 6 years within days. By utilizing AI and machine learning, Cognoa addresses the delays and inequities in autism diagnosis, providing a faster and more objective approach. The company is dedicated to transforming the landscape of child developmental health through innovative technology and a whole-child approach.Explore more
Cognoa Org Chart
Get the full picture
Sign in to uncover key details.
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Cognoa your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Earning: See what the market has to say on Cognoa recently announced quarterly report
Congratulate Masked Content for being promoted to Masked Content at Cognoa
Website visits: Recent activity has been detected on your website
Check if Cognoa has recently received funding, and reach out quickly before it becomes old news!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Product Launch: Get notified when Cognoa launches new products
Funding: Get notified immidiatlly once Cognoa has new funding data
Cognoa, which may be a good buyer, showed buying intent in Masked Content Topic
Click to see if Cognoa had a recent Job posting/layoffs
Check out if Cognoa is spiking on competitors!
Recommended Actions
Reach out to Masked Content who joined Cognoa as Masked Content
Find 3 more new buyers
Compare Similar Companies to Cognoa
Compare insights from companies similar to Cognoa, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Cognoa is experiencing very low activity levels compared to other companies in the Healthcare Services sector.
What does this means?
Cognoa is drawing exceptional interest within the Healthcare Services industry, suggesting notable developments or strong market momentum, learn more about Cognoa.
Cognoa financials insights
Gather financial insights about Cognoa, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2016
Series A
$3.8M
2017
Private Equity
$11.6M
Cognoa Tech Stack
A closer look at the technologies used by Cognoa
Most Recent Scoops
Person-Based
Medical Research, Public Health, Healthcare Technology
Person-Based
Person-Based
Event
Product Marketing, Events, Training, Sales, Digital Technology, Learning & Development, Medical Education & Training, Field /Outside Sales, Field Marketing, Healthcare Operations, Healthcare Technology, Medical Administration, Operations
Executive Move
Executive Moves, Board of Directors
Cognoa News & Media
Ability Center brings Cognoa's Canvas Dx to Saudi Arabia, giving families faster, more precise autism evaluations in early childhood
NEWPORT BEACH, Calif., Jan. 13, 2026 /PRNewswire/ -- Cognoa and The Ability Center today announced the exclusive availability in Saudi Arabia of Canvas Dx, the first ever FDA-authorized, AI-enabled pediatric autism diagnostic aid for children 18 to 72 months who have developmental delay...Cognoa Advocates for Expanded Insurance Coverage of Canvas Dx as CDC Reports 1 in 31 Children Now Identified with Autism
Recent CDC data reveals significant regional disparities in autism identification, highlighting the need for standardized, accessible diagnostic approaches nationwide. PALO ALTO, Calif., April 17, 2025 /PRNewswire/ -- In response to yesterday's Centers for Disease Control and Prevention...Wyoming Medicaid Becomes First State to Cover Cognoa's Canvas Dx, Expanding Access to Early Autism Diagnosis
New statewide policy empowers Wyoming healthcare professionals to diagnose autism with Canvas Dx, improving early access for families and delivering long term health and economic benefits PALO ALTO, Calif., Sept. 26, 2024 /PRNewswire/ -- Cognoa, a leading child development and behavioral...Cognoa Appoints Michael Butler as Board Executive Chair to Further Propel Access to First FDA Authorized Diagnostic for Autism
Having served as President of Providence for over 20 years, Mike Butler's leadership experience expanding healthcare access is poised to drive the reimbursement and clinical adoption of Canvas Dx, Cognoa's groundbreaking autism and child development diagnostic PALO ALTO, Calif., Sept. 10,...
Read more news
Top Healthcare Services Companies
Top companies in Australia by revenue
Frequently Asked Questions Regarding Cognoa
Sign Up For FreeTo access detailed company insights
Cognoa is a company focused on early childhood development and pediatric behavioral health, offering digital diagnostics and therapeutics aimed at improving access to care for children and families. Their flagship product, Canvas Dx, is the first FDA-authorized diagnostic solution that enables clinicians to diagnose or rule out autism in children a... Read More
